During the last few years the pharmaceutical houses have been competing to produce an intravenous barbiturate to supersede the long-established thiopentone. It is our duty as anmsthetists to assess these drugs very carefully, as they come on the market, before accepting unreservedly their place in anesthesia. We must bear in mind that, although the emphasis on these new drugs is short action and non-cumulation, a more important aspect must be to find a drug which is nonirritant and produces less depression on the cardiovascular and respiratory systems than thiopentone (Dundee 1956) .
In spite of the fact that the British Pharmacopoeia has always classified thiopentone as an ultra-short-acting barbiturate, it has long been recognized that it is not truly short acting: it is only short acting by virtue of its rapid localization into the fatty tissues. The effects of the drug may last many hours after consciousness has been regained owing to its slow return to the blood stream before final elimination from the body takes place. For this reason the cumulative effect is marked when repeated doses are used. As a contrast, the oxy-barbiturates, which include pentobarbitone and quinalbarbitone, behave rather differently. The localization in the tissues is less and the breakdown by the body is fairly rapid. For example, Gibson et al. (1959) , comparing compound 22451 with thiopentone, showed that, following repeated hourly injections, the recovery time with this oxy-barbiturate was less than one hour, after eight hours' administration, yet with thiopentone it was greater than one hour, after only three hours' administration.
Consequently, the appearance on the clinical market of an apparently ultra-short-acting oxybarbiturate, compound 25398, the a-dl isomer of compound 22451, has created much interest in the realms of out-patient anesthesia.
It has been shown that this compound, now known as methohexitone, requires a concentration in the plasma approximately half to onethird that of thiopentone to produce anesthesia. Also the degree of cumulation has been shown to be similar to that of the previous compound.
Most of the human clinical trials with methohexitone have taken the form of a comparison with thiopentone and all confirm the early claims that a quicker recovery time is seen. These studies were fortunately preceded by a number of investigations to determine the relative potency between the two drugs. As a result of this the common error of mistaking low potency for short action was avoided.
Among the many workers who studied this problem, Bellville et al. (1960) , using servocontrolled cross-over experiments in dogs, found the potency of methohexitone relative to thiopentone to be 3 07 :1. Wyant & Barr (1960), using patients for dilatation and curettage, found a relative potency of 2-4 : 1 and Green & Jolly (1960) , using repeated injections for patients undergoing ECT, found 3 1: 1.
Many more investigators have compared the recovery times with these two drugs. For example, Friedman (1959 ), Redish et al. (1958 ), Jolly (1960 and others have all confirmed the original claim that recovery following methohexitone is more rapid than that following thiopentone. They do little, however, to establish the degree of recovery produced after a stated time with a specific dose. If we are to accept the use of these drugs in outpatient surgery we must be able to assess with confidence when our patients are fully recovered, purely on clinical observations. The estimation of blood levels can be of no value to us. We must be reasonably certain that whatever our patient does when he leaves the surgery, he will be able to do as well and with as much sense ofresponsibility as when he entered it. We have no guarantee that our patient, although he may leave the clinic accompanied, will not drive away in a car or go to work where he may have to operate some intricate or dangerous piece of machinery.
In 1960 we attempted to investigate more specifically the recovery after methohexitone anesthesia used for the induction of dental anesthesia with special reference to our ability to assess recovery clinically and therefore the effects the drug might have on our patients after leaving our care. The result of this investigation and the technique used has been described previously (Green & Jolly 1960) .
The results were not entirely reassuring. Although we were very particular not to let any patient leave the clinic before we were satisfied that he was fully recovered, 16% of the patients felt the need to lie down after returning home and therefore may have been suffering from delayed action of either the anesthetic or the operation. It is difficult to assess which. Only one reported any difficulty in getting home; this was because of faintness.
As a result of these findings and because of the lack of information concerning the relationship between assessed clinical recovery after the barbiturates and complete performance recovery, I decided to seek a clinical experiment which might provide this information. Requiring a performance task which would need both skill and a power of sustained concentration to perform, I approached the Royal Society for Prevention of Accidents for their advice concerning the possible use of a Miles Trainer Car. After preliminary experiments they referred me to the Road Research Institute at Langley, where the Medical Research Council have a laboratory equipped with a Miles Trainer Car and recording gear.
With the help of Miss H A Long, who had been using the apparatus to assess performance under the influence of alcohol (Drew et al. 1959) , Dr Jolly in the preliminary stages, and Drs C J R
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Elliott and T H Howells, we planned an experiment which might also have some application in the investigation of future drugs. The object of the investigation was to equate the assessment of clinical recovery with performance recovery and also to compare the performance recovery after methohexitone and thiopentone. The subjects were all student volunteers from The Royal Free Hospital and St George's Hospital. There were 8 men and 12 women.
The apparatus (Fig 1) consisted of a car which was connected by means of its steering wheel and accelerator to a movable landscape disc, on which was mapped a road surface. A fixed lamp assembly projected a shadow of the landscape on to a screen which separated the car from the rest of the apparatus. The recording gear was also located behind the screen.
The trainer ( Fig 2) was a stationary machine equipped with gears, clutch, brake and all essential accessories of a modern car. There was also a reaction-timing device attached to the brake, which the driver operated when a red light appeared on the screen.
The driving circuit (Fig 3) could be as simple or as complicated as desired. For this experiment we had to have a continuous circuit in order to facilitate recording, but the bends were made fairly sharp so as to increase the difficulty of the task.
We found that this circuit was such that the subjects were not able to anticipate corners during the course of the experiments.
The operation of the apparatus was dependent upon a fixed light which cast a shadow of the road in front of it on to the screen and the recording depended upon movement of a spring-loaded arm which ran along the left hand curb of the track (Fig 4) . Any deviation from a normal course was recorded. The view of the road from the driving seat was described as like driving along an unlit road into a setting sun, so the conditions were difficult and exacting. All recordings were made out of sight of the driver and the human error of recording was eliminated by the use of a camera.
The main aspects of performance measured were: Accuracy of tracking, i.e. deviation from a pre-selected position on the road; speed of driving; amount of steering wheel movement; reaction time. To eliminate errors due to unfamiliarity with the apparatus, and to learning during the course of the experiments, all the subjects had periods of training on the apparatus until a consistent level of performance was achieved.
All trials were carried out in the morning, the subjects having fasted since the previous evening and having had a good night's sleep. Immediately before each experiment the subjects were given a fifteen-minute recorded driving period in order to establish a pre-drug performance level.
The drugs were made up by the hospital dispenser in ampoules labelled with the subject's name and the dispenser alone had the key to the order of drug administration. The thiopentone was made in a 3 % solution and the methohexitone in 1 % solution, the methohexitone being coloured with riboflavin to simulate the yellow colour of thiopentone so that neither the experimenter nor the subject knew which drug was being administered. Thiopentone was given in a dose of 2-64 mg/kg and methohexitone 0-88 mg/kg body weight, which is slightly greater than the dose used for the dental anesthetic trials (namely 0-88 mg/kg rather than 0O78 mg/kg).
The injection was made with the subject in the sitting position and-was given over a period of ten seconds. During the period of sleep the subject was asked to open his eyes and wake up at repeated intervals. The response to this command gave us the sleeping time, which was longer with methohexitone (2-25 min) than with thiopentone (2 min).
Five minutes after the drug was administered the subject was tested for clinical recovery and moved to the car. Within seven minutes the driving trial was commenced. The subjects were asked to drive on the left side of the road and as accurately as they were able. The performance task consisted of three periods of seven minutes driving. After each period, they got out of the car and a clinical assessment of recovery was made. Fortyfive minutes after injection a rest period of fifteen minutes was given, followed by a further fifteen minutes of driving.
Clinical Recovery
The clinical assessment was made up to thirty-five minutes after injection. The results, which were analysed at the end of the experimental-series, show a marked difference between methohexitone and thiopentone (Table 1) , but a slower recovery rate than that reported in the dental series. This was probably due to some feeling of fatigue which could be experienced by the subjects using the machine for long periods without drugs. This clinical assessment also revealed that euphoria occurred two or three times more frequently after methohexitone than after thiopentone.
Performance ecovery
Although during the post-drug driving period all the subjects were clinically under the influence of the drugs, by hto means all showed a deterioration in performance as measured by the tracking error ( Fig 5) . A few subjects showed a relatively large deterioration during the first two driving periods. The majority of these incidences occurred with thiopentone, but the difference between the drugs was not significant. The individual differences in drug effect were, however, significantly greater with thiopentone than with methohexitone. The reaction time was longer with both drugs in 80 % of the subjects during the first driving period.
By the third driving period, forty minutes after the injection of methohexitone, all the subjects had returned to normal or better than normal, whereas, even seventy minutes after the injection of thiopentone, the reaction time was still impaired in the majority of subjects. These results are in agreement with those of Eckenhoff, who, using a complex reaction timer and considerably larger doses of both drugs, found that the return to normal reaction time occurred significantly earlier with methohexitone than with thiopentone (Egbert et al. 1959) .
A comparison of the subjects' reaction time with their ability to perform this task accurately showed considerably better performance than would be expected from the reaction-time figures. This was probably due to the fact that with these drugs the subjects appeared fully aware of their condition and so performed the task more slowly and with more care during the early part of the experiments. There seemed to be no decrease in their ability to concentrate. This pattern of performance is quite unlike that which occurs with alcohol, when considerable deterioration of performance has been demonstrated in the absence of clinical evidence of drug effect, on the same apparatus (Drew et al. 1959) .
We were unable to find any clear evidence of a deterioration in the driving task, in the absence of clinical symptoms, with either thiopentone or methohexitone. It may therefore be said that both drugs are suitable for out-patient surgery so far as the assessment of recovery is concerned, but the far more rapid recovery after methohexitonemakes this drug more desirable.
In practice a clinical recovery ranging from fifteen to thirty-five minutes is quite acceptable; as no marked performance deterioration could be detected after ten minutes the margin of safety was considerable.
These observations apply to the use of small single doses; the use of large or repeated doses may present a different problem. We know from many years' experience that the prolonged use of thiopentone leads to considerable tissue accumulation and delayed recovery. For example, Brodie et al. (1950) found that five hours after the administration of 3-8 g of thiopentone the plasma concentration had only fallen by 20% of the value immediately prioi to stopping the administration.
Therefore, as a corollary to this experiment, the effects of prolonged administration of methohexitone have been studied by using the drug as the sole hypnotic agent in major surgery, analgesia being achieved by use ofan extradural block.
The technique used has been as follows: a 0or 0-2% methohexitone drip was set up on the lightly premedicated patients in the aneesthetic room. The drip was run at a fast rate until sleep was produced. Each patient was then turned on his side and an extradural block introduced with 1.5% plain lignocaine; a catheter was left in situ for further administration. During the period of the operation the patients breathed air and light sleep was maintained by adjusting the drip as required. An artificial airway was seldom used.
The drip was discontinued five minutes before the anticipated end of the operation.
The quantity of the drug used and the rate of recovery have been analysed in 81 patients anwsthetized in this way. The total dose used ranged from 1,250 mg during a colectomy lasting three and a half hours to 220 mg in an elderly woman for a vaginal hysterectomy lasting forty-five minutes. This dose depended to a great extent upon the length of the operation, age and weight of the patient, but could also be influenced considerably by the care taken to maintain a light plane of anisthesia throughout the operation.
The average dose in this small series of cases was 50 mg/kg/hour. The average dose given in every thirty-minute period of administration is shown in Table 2 . There is some evidence of a cumulative effect, but it must be remembered that after the first fifteen to twenty minutes the absorption of the lignocaine will begin to have some effect. The mean recovery time was 8-7 minutes after stopping the drip. I judged the patient to be recovered when he was awake and could maintain a co-ordinated conversation. In only 3 patients did the recovery time exceed fifteen minutes.
These results support the belief that the cumulative effects of methohexitone are far less than those previously reported with thiopentone.
This rapid recovery after prolonged administration of methohexitone can be of advantage in many other surgical procedures, where light sleep is desirable and the operation itself is painless or can be made so by local anesthesia. For example, it has been used most successfully during chemopallidectomy, cardiac catheterization and a number of other diagnostic procedures where rapid recovery is required. Dr Victor Goldman (London) read a paper on Methohexitone Induction of Anesthesia in the Dental Chair (Goldman & Harris 1963) . He stressed the absence of local effects on the tissues, and the convenience of a prepared solution that could be stored for several months, indicating that methohexitone was a most desirable induction agent in the ambulant patient. The dosage for this purpose should not be empirical but closely related to the weight of the patient and his nervous state. He gave warning that because of its extremely transient action methohexitone should not be used as an induction-agent when a relaxant was to follow, especially when the patient was unpremedicated (Danziger 1962), but he found it a valuable agent for induction in major surgery for elderly and diabetic cases when a rapid recovery was advisable.
Dr A H Galley (King's College Hospital, London) described the course of three dental anesthetics given to a man of 27 years who was reputed to be resistant to anesthesia. On the first two occasions, he was induced with thiopentone 250 mg and maintained with nitrous oxide, oxygen (20 %) and halothane, both administrations being uneventful. On the third occasion he was induced with methohexitone 80 mg followed by nitrous oxide and oxygen (25 %) as soon as he fell asleep. Some seconds later generalized epileptiform convulsions developed and persisted for about twentyfive seconds during which time the nitrous oxide was turned off and oxygen (100%) substituted.
When the convulsions stopped the patient had a good colour and pulse and, almost immediately, regular rhythmic respirations returned. The extractions were completed under nitrous oxide, oxygen (20 %) and a little halothane. The patient soon awakened, having been unconscious for just over six minutes; he was, however, rather dazed for another five or six minutes although able to walk to the recovery room. Later, he gave a history of grand mal until he was about 10 years old (when treatment was discontinued) and said he had no fits after this as far as he knew. Two sisters had been similarly affected, one of them (30 years old) being still under treatment. Subsequent EEG tracings from the male patient showed him to be a crypto-epileptic.
Dr Galley recalled that many barbiturates evoked restlessness and some were known to be convulsants without any sedative properties whatever. He)6barbitone by itself was accompanied by rhythmic shuddering movements of
